Based on the information available, there is no explicit age restriction for patients seeking assistance with Vascepa through the patient aid program. However, the specific eligibility criteria may vary depending on the program. It is recommended to directly contact Vascepa's patient aid program or visit their official website for the most accurate and up-to-date information.

For further context, Vascepa is a prescription medication used to help reduce the risk of cardiovascular events in adults with elevated triglyceride levels. The active ingredient in Vascepa is icosapent ethyl, which is a form of omega-3 fatty acid.

For more information on Vascepa and its patent status, please refer to DrugPatentWatch.com: [DrugPatentWatch.com: Vascepa (Icosapent Ethyl) - Patent Expiration & Drug Savings](https://www.drugpatentwatch.com/drugs/vascepa)

Sources:

1. DrugPatentWatch.com: Vascepa (Icosapent Ethyl) - Patent Expiration & Drug Savings. (n.d.). Retrieved from <https://www.drugpatentwatch.com/drugs/vascepa>